MENU
BHVN
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Biohaven (BHVN) Ownership - Who owns Biohaven?

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology... Show more

Profile

Industry
Pharmaceuticals Major
Address
215 Church Street
Phone
+1 203 404-0410
Employees
239
Web
https://www.biohavenpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.7B
P/E Ratio
N/A
Total Cash
347.82M
Projected Growth
N/A
Total Debt
286.18M
Revenue
N/A
Risk (Beta)
1.77
Dividend Yield
N/A
Total Cash/Share
2.31
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
BHVN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical drugs

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
215 Church Street
Phone
+1 203 404-0410
Employees
239
Web
https://www.biohavenpharma.com